Next report date
Report period
Q1 2024
EPS estimate
—
Revenue estimate
—
1.076CHF
57.96 MCHF
1.06 BCHF
17.17 M
About DERMAPHARM HLDG SE
Sector
CEO
Hans-Georg Feldmeier
Headquarters
Grunwald
Website
Founded
2017
FIGI
BBG00LVD7663
Dermapharm Holding SE engages in the development, manufacture and market of patent-free pharmaceutical products. The company operates through the Branded pharmaceuticals and other healthcare products, Parallel import business and Herbal extracts divisions. Its products include covers prescription pharmaceuticals (Rx), over-the-counter (OTC) products, medical devices, food supplements and cosmetics. The company was founded in 1991 and is headquartered in Grunwald, Germany.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of DMP is 32.077 CHF — it has decreased by 17.98% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on BX exchange DERMAPHARM HLDG SE stocks are traded under the ticker DMP.
DERMAPHARM HLDG SE is going to release the next earnings report on May 15, 2024. Keep track of upcoming events with our Earnings Calendar.
DMP stock is 25.47% volatile and has beta coefficient of 0.52. Check out the list of the most volatile stocks — is DERMAPHARM HLDG SE there?
DMP earnings for the last quarter are 0.27 CHF per share, whereas the estimation was 0.72 CHF resulting in a −62.50% surprise. The estimated earnings for the next quarter are 0.92 CHF per share. See more details about DERMAPHARM HLDG SE earnings.
DERMAPHARM HLDG SE revenue for the last quarter amounts to 316.62 M CHF despite the estimated figure of 306.60 M CHF. In the next quarter revenue is expected to reach 256.79 M CHF.
Yes, you can track DERMAPHARM HLDG SE financials in yearly and quarterly reports right on TradingView.
DMP net income for the last quarter is −2.50 M CHF, while the quarter before that showed 24.04 M CHF of net income which accounts for −110.41% change. Track more DERMAPHARM HLDG SE financial stats to get the full picture.
Today DERMAPHARM HLDG SE has the market capitalization of 1.65 B, it has decreased by 2.27% over the last week.
Yes, DMP dividends are paid annually. The last dividend per share was 1.03 CHF. As of today, Dividend Yield (TTM)% is 3.35%. Tracking DERMAPHARM HLDG SE dividends might help you take more informed decisions.
Like other stocks, DMP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DERMAPHARM HLDG SE stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So DERMAPHARM HLDG SE technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating DERMAPHARM HLDG SE stock shows the sell signal. See more of DERMAPHARM HLDG SE technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on DERMAPHARM HLDG SE future price: according to them, DMP price has a max estimate of 56.39 CHF and a min estimate of 40.35 CHF. Read a more detailed DERMAPHARM HLDG SE forecast: see what analysts think of DERMAPHARM HLDG SE and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. DERMAPHARM HLDG SE EBITDA is 294.93 M CHF, and current EBITDA margin is 26.86%. See more stats in DERMAPHARM HLDG SE financial statements.